Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

PI3K in stemness regulation: from development to cancer.

Madsen RR.

Biochem Soc Trans. 2020 Feb 3. pii: BST20190778. doi: 10.1042/BST20190778. [Epub ahead of print]

PMID:
32010943
2.

Cracking the context-specific PI3K signaling code.

Madsen RR, Vanhaesebroeck B.

Sci Signal. 2020 Jan 7;13(613). pii: eaay2940. doi: 10.1126/scisignal.aay2940. Review.

PMID:
31911433
3.

Scientific impact and the quest for visibility.

Madsen RR.

FEBS J. 2019 Oct;286(20):3968-3974. doi: 10.1111/febs.15043. Epub 2019 Aug 29.

PMID:
31468701
4.

Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling.

Harman JL, Dobnikar L, Chappell J, Stokell BG, Dalby A, Foote K, Finigan A, Freire-Pritchett P, Taylor AL, Worssam MD, Madsen RR, Loche E, Uryga A, Bennett MR, Jørgensen HF.

Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2289-2302. doi: 10.1161/ATVBAHA.119.312765. Epub 2019 Aug 22.

5.

Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability.

Vanhaesebroeck B, Bilanges B, Madsen RR, Dale KL, Lau E, Vladimirou E.

Biomolecules. 2019 Aug 1;9(8). pii: E331. doi: 10.3390/biom9080331. Review.

6.

Luminescent peptide tagging enables efficient screening for CRISPR-mediated knock-in in human induced pluripotent stem cells.

Madsen RR, Semple RK.

Version 3. Wellcome Open Res. 2019 Jul 11 [revised 2019 Jan 1];4:37. doi: 10.12688/wellcomeopenres.15119.3. eCollection 2019.

7.

Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner.

Madsen RR, Knox RG, Pearce W, Lopez S, Mahler-Araujo B, McGranahan N, Vanhaesebroeck B, Semple RK.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8380-8389. doi: 10.1073/pnas.1821093116. Epub 2019 Apr 4.

8.

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders.

Madsen RR, Vanhaesebroeck B, Semple RK.

Trends Mol Med. 2018 Oct;24(10):856-870. doi: 10.1016/j.molmed.2018.08.003. Epub 2018 Sep 6. Review.

9.

Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients.

Fernebro E, Madsen RR, Fernö M, Brünner N, Bendahl P, Christensen IJ, Johnson A, Nilbert M.

Eur J Cancer. 2001 Mar;37(4):486-91.

PMID:
11267858

Supplemental Content

Loading ...
Support Center